Results 211 to 220 of about 52,204 (292)
ABSTRACT Although much research focuses on the effects of hyperglycemia during pregnancy on maternal and offspring health, this narrative review specifically centers on the role of insulin resistance (IR) in pregnancy complications and offspring long‐term health.
Runyu Du, Fei Wang, Ling Li, Qiuyue Wang
wiley +1 more source
Long-Term Survival in a Dog After Adrenalectomy and Splenectomy for Two Different Malignancies with Portal Vein Involvement. [PDF]
Kim SH +4 more
europepmc +1 more source
Hydatid disease limited to bilateral adrenal glands mimicking tuberculosis
Atay Uludokumaci +5 more
openalex +1 more source
Pheochromocytoma crisis combined with median arcuate ligament syndrome: A rare case report. [PDF]
Wen JX, Li WJ, Guo J, Siliath H, Xiao Y.
europepmc +1 more source
Exposure to artificial light at night (ALAN), particularly at blue wavelengths, disrupts circadian rhythms by suppressing melatonin, thereby increasing cancer susceptibility. This systematic review consolidates evidence linking prolonged ALAN exposure to an elevated risk of breast and prostate tumors.
Gabriel Barboza +4 more
wiley +1 more source
Beyond the Classical Axis: Metabolic "Pressure" on the Adrenal Gland? [PDF]
Isidori AM, Pofi R, Fleseriu M.
europepmc +1 more source
Case Report: Challenges of an extremely delayed diagnosis of classic congenital adrenal hyperplasia in a completely virilized 46,XX patient. [PDF]
Casiraghi A +5 more
europepmc +1 more source
ABSTRACT Canine phaeochromocytomas (PCCs) are neuroendocrine tumours with malignant potential. Metastatic disease remains the sole definitive evidence of malignancy. Histopathological criteria to predict long‐term survival have not been established in dogs.
Marit F. van den Berg +6 more
wiley +1 more source
Morphological and Transcriptomic Analyses of the Adrenal Gland in <i>Acomys cahirinus</i>: A Novel Model for Murine Adrenal Physiology. [PDF]
Bilyalova A +14 more
europepmc +1 more source
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma
ABSTRACT Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for anti‐angiogenic oncotherapy, as inhibiting this receptor on tumour vasculature slows tumour development and enhances drug‐ and immune infiltration, improving therapy outcome.
Esther Hindriks +5 more
wiley +1 more source

